Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to -$4.8 million.

  • Cross Country Healthcare's Net Income towards Common Stockholders fell 28684.93% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.7 million, marking a year-over-year decrease of 78815.86%. This contributed to the annual value of -$14.6 million for FY2024, which is 12004.1% down from last year.
  • Latest data reveals that Cross Country Healthcare reported Net Income towards Common Stockholders of -$4.8 million as of Q3 2025, which was down 28684.93% from -$6.7 million recorded in Q2 2025.
  • Cross Country Healthcare's 5-year Net Income towards Common Stockholders high stood at $77.6 million for Q4 2021, and its period low was -$16.0 million during Q2 2024.
  • In the last 5 years, Cross Country Healthcare's Net Income towards Common Stockholders had a median value of $12.8 million in 2023 and averaged $19.1 million.
  • Per our database at Business Quant, Cross Country Healthcare's Net Income towards Common Stockholders soared by 170907.18% in 2021 and then tumbled by 28684.93% in 2025.
  • Over the past 5 years, Cross Country Healthcare's Net Income towards Common Stockholders (Quarter) stood at $77.6 million in 2021, then plummeted by 53.19% to $36.3 million in 2022, then crashed by 75.11% to $9.0 million in 2023, then tumbled by 141.52% to -$3.8 million in 2024, then dropped by 27.2% to -$4.8 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$4.8 million for Q3 2025, versus -$6.7 million for Q2 2025 and -$490000.0 for Q1 2025.